News
GlobalData on MSN12d
Sabin Vaccine Institute begins trial of vaccine candidate for Marburg virus diseaseThe Sabin Vaccine Institute has begun a Phase II trial in the US to evaluate its Marburg vaccine, with the first doses being ...
The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, ...
Jonathan Rockoff is the Health Business editor at The Wall Street Journal, managing a team that reports on pharmaceutical and biotechnology companies, health insurers and hospitals. During the ...
The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the ...
When COVID-19 began tearing across the world in spring 2020, there were no vaccines to protect against the virus. To help accelerate ... The WHO has labeled vaccine hesitancy as one of the top ...
The disease is caused by the Marburg filovirus, which belongs to the Ebola virus family. Sabin’s investigational vaccine ... the institute contributed to an open-label Phase II trial by supplying the ...
Consumers can also help by purchasing wood and paper products with the Forest Stewardship Council ® (FSC ®) label ... Sierra Leone. Ebola likely originates in fruit bats, porcupines, and nonhuman ...
Filoviruses are among the globe's most lethal—indeed, so dangerous they can be handled only in high-security laboratories.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results